Abbott's Humira Defense May Be Linked To Counter-Suit In Massachusetts
Executive Summary
Abbott is looking to the federal appeals court, and a district court in Massachusetts, to shore up its Humira franchise after a Texas jury issued a $1.67 billion verdict against it, finding that the firm's top-selling drug infringes a patent owned by Johnson & Johnson